117 related articles for article (PubMed ID: 9247857)
1. Novel selective thiol inhibitors of neutral endopeptidase containing heterocycles at P'2 position.
Norcini G; Morazzoni G; Pocchiari F; Santangelo F; Semeraro C
J Enzyme Inhib; 1997 Jun; 12(2):155-60. PubMed ID: 9247857
[No Abstract] [Full Text] [Related]
2. New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
Fink CA; Qiao Y; Berry CJ; Sakane Y; Ghai RD; Trapani AJ
J Med Chem; 1995 Dec; 38(26):5023-30. PubMed ID: 8544178
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.
Olins GM; Krieter PA; Trapani AJ; Spear KL; Bovy PR
Mol Cell Endocrinol; 1989 Feb; 61(2):201-8. PubMed ID: 2521834
[TBL] [Abstract][Full Text] [Related]
4. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
[TBL] [Abstract][Full Text] [Related]
5. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
[TBL] [Abstract][Full Text] [Related]
7. Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
Roksnoer LC; van Veghel R; de Vries R; Garrelds IM; Bhaggoe UM; Friesema EC; Leijten FP; Poglitsch M; Domenig O; Clahsen-van Groningen MC; Hoorn EJ; Jan Danser AH; Batenburg WW
Kidney Int; 2015 Jul; 88(1):109-20. PubMed ID: 25830765
[TBL] [Abstract][Full Text] [Related]
8. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
Solter P; Sisson D; Thomas W; Goetze L
J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
[TBL] [Abstract][Full Text] [Related]
9. pH- and time-dependent inhibition of rat kidney neutral endoprotease 24.11 by thiorphan and phosphoramidon.
Jeng AY; Ansell J; Erion MD
Life Sci; 1989; 45(22):2109-14. PubMed ID: 2601566
[TBL] [Abstract][Full Text] [Related]
10. Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat.
Dalzell JR; Seed A; Berry C; Whelan CJ; Petrie MC; Padmanabhan N; Clarke A; Biggerstaff F; Hillier C; McMurray JJ
Cardiovasc Ther; 2014 Feb; 32(1):13-8. PubMed ID: 24138103
[TBL] [Abstract][Full Text] [Related]
11. Neutral endopeptidase inhibitors and atrial natriuretic peptide.
Achilihu G; Frishman WH; Landau A
J Clin Pharmacol; 1991 Aug; 31(8):758-62. PubMed ID: 1831818
[TBL] [Abstract][Full Text] [Related]
12. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
Gros C; Souque A; Schwartz JC
Eur J Pharmacol; 1990 Apr; 179(1-2):45-56. PubMed ID: 2142086
[TBL] [Abstract][Full Text] [Related]
14. New enkephalinase inhibitors as probes to differentiate "enkephalinase" and angiotensin-converting-enzyme active sites.
Roques BP; Fournié-Zaluski MC; Florentin D; Waksman G; Sassi A; Chaillet P; Collado H; Costentin J
Life Sci; 1982 Oct 18-25; 31(16-17):1749-52. PubMed ID: 6296575
[No Abstract] [Full Text] [Related]
15. Phosphonamide inhibitors of neutral endopeptidase (EC 3.4.24.11).
Norcini G; Morazzoni G; Pocchiari F; Santangelo F; Semeraro C
J Enzyme Inhib; 1997 Apr; 12(1):71-7. PubMed ID: 9204384
[No Abstract] [Full Text] [Related]
16. Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.
Peyroux J; Beslot F; Claperon N; Fournie-Zaluski MC; Roques BP
Br J Pharmacol; 1995 Dec; 116(8):3117-24. PubMed ID: 8719785
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.
Olimpieri F; Tambaro S; Fustero S; Lazzari P; Sanchez-Roselló M; Pani L; Volonterio A; Zanda M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4715-9. PubMed ID: 19596577
[TBL] [Abstract][Full Text] [Related]
18. The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11.
Stephenson SL; Kenny AJ
Biochem J; 1987 Apr; 243(1):183-7. PubMed ID: 3038078
[TBL] [Abstract][Full Text] [Related]
19. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme and neutral endopeptidase modulate smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa in vivo.
Gao XP; Suzuki H; Olopade CO; Pakhlevaniants S; Rubinstein I
J Lab Clin Med; 1997 Oct; 130(4):395-400. PubMed ID: 9358078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
